in vivo immunomodulation was assessed by natural killer ( nk ) cytotoxicity , monocyte activation as determined by cell surface expression of hla-dr , and peripheral blood mononuclear cell phenotype analysis by flow cytometry .
C0678889
immunomodulation
C0019764
hla-dr